NMN Transport and Cellular Uptake

Why this is more complicated than "NMN enters cells directly"

A common shorthand in supplement marketing is that NMN "enters cells directly" to boost NAD+. The actual science is more layered than that sentence suggests, and conflates several genuinely different claims — some well established, some based only on animal or cell studies, and one that is actively disputed among researchers. This page separates those claims explicitly, using four categories: ESTABLISHED (settled, reproducible science), PRECLINICAL (supported in animal or cell models, not directly confirmed in humans), DISPUTED (a specific claim that other scientists have directly challenged), and UNRESOLVED (a real open question with no confirmed answer yet).

ESTABLISHED: NMN cannot simply diffuse across a cell membrane

NMN carries a phosphate group that makes it too large and electrically charged to pass through a lipid cell membrane by simple diffusion — this is basic, uncontested membrane biophysics, true of phosphorylated molecules generally.[1] Whatever route NMN takes into a cell, it is not passive diffusion; some active transport step, membrane-associated processing, or prior chemical conversion is required.

ESTABLISHED: oral NMN is followed by higher blood NAD+ in human trials

Separately, and just as firmly established: multiple randomized, placebo-controlled human trials report that oral NMN supplementation raises blood NAD+ and related metabolites — see NMN Dosage for the full set of trials.[2] This tells us that whatever route NMN or its breakdown products take, oral administration is followed by a measurable systemic effect in humans. It does not, by itself, tell us the mechanism — and mechanism is what the rest of this page addresses.

PRECLINICAL: extracellular conversion before uptake

A well-supported model, built primarily on cell and tissue studies, holds that an enzyme called CD73, sitting on the outside of cells, strips the phosphate group off extracellular NMN, converting it into nicotinamide riboside (NR) — a smaller, uncharged molecule that established transporters can carry into the cell, where it is converted back into NMN and then NAD+.[3] This route is grounded in laboratory cell and tissue biology, not in a human study designed to trace the pathway directly in people — which is why it belongs in the PRECLINICAL category rather than ESTABLISHED.

DISPUTED: the SLC12A8 transporter proposal

In 2019, one research group reported identifying a protein called SLC12A8 as a dedicated NMN transporter, based on experiments in mouse intestinal tissue and cell lines — a direct transport route that, if confirmed, would not require the extracellular NR-conversion step above.[4] That same year, a separate group published a direct scientific challenge, arguing that the transport measurements and analytical methods underlying the original claim did not actually support the conclusion that SLC12A8 moves NMN across membranes.[5] The original authors published a rebuttal defending their methodology. The dispute was never definitively resolved in the published literature, and no independent replication has settled it either way. This entire exchange concerns mouse tissue — no study has tested or confirmed SLC12A8 as an NMN transporter in humans.

UNRESOLVED: what remains genuinely unknown

Put together, the honest state of the science is: oral NMN reliably raises blood NAD+ markers in human trials, and NMN cannot cross a membrane unassisted — but the specific route between those two facts (extracellular conversion to NR, a direct transporter such as SLC12A8, some combination, additional routes not yet identified, or meaningful differences between tissues) has not been established in humans. This is a genuine open question in the field, not a settled mechanism with minor caveats.

What this page is not claiming

None of this uncertainty about mechanism changes the human trial evidence on blood NAD+ response covered on NMN Dosage — that evidence stands on its own. What it does mean is that a specific mechanistic claim like "NMN enters cells via SLC12A8" or "NMN enters cells directly" overstates what is currently known, and should be read with the ESTABLISHED / PRECLINICAL / DISPUTED / UNRESOLVED distinctions above in mind.

Related reading

For the consumer-facing version of this topic, including what this means practically, see How NMN Is Absorbed and Metabolized. For the enzymes NMN feeds into once inside a cell, see NMNAT Enzymes Explained.